25 Aug 2020 Governance
Angela Smith-Morgan to step down from her role as Co CEO of Leukaemia UK
After eight successful years with us, Angela Smith-Morgan will be stepping down from her role as Co CEO of Leukaemia UK on 3rd September.
Angela was responsible for driving through the merger with Leuka in November 2019, and is now leaving the charity in a strong position to build on the remarkable transformation she engineered.
She has been a valued Co CEO of the merged charity and a visionary sole CEO of the original charity. We thank her for her outstanding work on our behalf and wish her the very best in the future.
Related posts
18 May 2022
World Blood Cancer Day interview with Dr Pramila Krishnamurthy
On 28th May the global blood cancer community comes together to mark World Blood Cancer Day, this campaign calls for support of those with blood cancer and encourages people to become stem cell donors.
18 November 2024
Leukaemia UK’s Patient Care Pioneer Award fuels innovative research to revolutionize ‘watch and wait’ approach
Leukaemia UK is excited to announce Professor Francesco Forconi from University Hospital Southampton (UHS) as the first recipient of its Patient Care Pioneer Award. Through this new funding initiative, Professor…
29 February 2024
Nurse who made throwaway comment before blood cancer diagnosis welcomes new research boost into ‘Natural Killer’ cells
A former nurse, midwife, health visitor and NHS manager is welcoming new research into her particular blood cancer, after not recognising her mystery symptoms were leukaemia. Kay Cutting, from Seaham…
1 August 2022
A research breakthrough targets cancer over healthy tissue, bringing possibility of a new treatment option for most deadly type of leukaemia
A new scientific paper published on 22nd June in Science Translational Medicine, announced a breakthrough by Leukaemia UK-funded scientist Dr William Grey that could lead to a vital new treatment option for…